PMNProMIS Neurosciences, Inc.

PMN Stock Price, Valuation & Chart | ProMIS Neurosciences, Inc.

Compare

$13.970+0.62 (+4.68%)

At close · 02 Sept 2026, 08:00 pm

Sector: Healthcare Industry: Biotechnology PMN intrinsic value PMN calculated fair value vs price

Overview Financials Dividends Ratios

PMN Historical price chart

PMN Key Stats

Fair Value

Disclaimer

Disclaimer: This fair value estimate is for informational purposes only and should not be considered as investment advice. Fair value calculations are based on DCF (Discounted Cash Flow), P/E Multiple, and P/S Multiple models and assumptions that may not reflect actual market conditions. Always conduct your own research and consult with a financial advisor before making investment decisions.

Unlock

Market Capitalization18.27M

PE Ratio-1.2

EPS-11.66

Trading Volume89.57K

Today's High/Low14.28/13.27

Dividend Yield0.00

52 Week High/Low27.4/6.27

Shares Outstanding1.31M

PMN Financial Statement

PMN Analyst ratings

PMN Analysis & performance metrics

PMN Company profile

ProMIS Neurosciences, Inc. discovers and develops precision medicine solutions for the treatment of neurodegenerative diseases, primarily Alzheimer's disease (AD),…

ProMIS Neurosciences, Inc. discovers and develops precision medicine solutions for the treatment of neurodegenerative diseases, primarily Alzheimer's disease (AD), amyotrophic lateral sclerosis (ALS), and multiple system atrophy (MSA) in Canada. The company's proprietary discovery platform comprises ProMIS and Collective Coordinates algorithms to predict novel targets known as disease…

PMN Management team

Name

Position

Larry Douglas Altstiel M.D., Ph.D.

Chief Medical Officer

Neil K. Warma M.B.A.CEO

Chief Executive Officer, President, Compliance Officer & Director

Eugene W. Williams

Co-Founder & Chairman

Neil R. Cashman M.D.CTO

Co-Founder, Co-Chairman of Scientific Advisory Board, Chief Scientific Officer & Director

Daniel E. Geffken M.B.A.CFO

Chief Financial Officer

Johanne Kaplan Ph.D.

Chief Development Officer

David Wishart Ph.D.

Chief Physics Officer

Dennis Chen Ph.D.

Head of Manufacturing & Senior Consultant

Name

Position

Larry Douglas Altstiel M.D., Ph.D.

Chief Medical Officer

Neil K. Warma M.B.A.CEO

Chief Executive Officer, President, Compliance Officer & Director

Eugene W. Williams

Co-Founder & Chairman

Neil R. Cashman M.D.CTO

Co-Founder, Co-Chairman of Scientific Advisory Board, Chief Scientific Officer & Director

Daniel E. Geffken M.B.A.CFO

Chief Financial Officer

Johanne Kaplan Ph.D.

Chief Development Officer

David Wishart Ph.D.

Chief Physics Officer

Dennis Chen Ph.D.

Head of Manufacturing & Senior Consultant

Management Team

Larry Douglas Altstiel M.D., Ph.D.

Chief Medical Officer

Neil K. Warma M.B.A.CEO

Chief Executive Officer, President, Compliance Officer & Director

Eugene W. Williams

Co-Founder & Chairman

Neil R. Cashman M.D.CTO

Co-Founder, Co-Chairman of Scientific Advisory Board, Chief Scientific Officer & Director

Daniel E. Geffken M.B.A.CFO

Chief Financial Officer

Johanne Kaplan Ph.D.

Chief Development Officer

David Wishart Ph.D.

Chief Physics Officer

Dennis Chen Ph.D.

Head of Manufacturing & Senior Consultant

Management

Larry Douglas Altstiel M.D., Ph.D.

Chief Medical Officer

Neil K. Warma M.B.A.CEO

Chief Executive Officer, President, Compliance Officer & Director

Eugene W. Williams

Co-Founder & Chairman

Neil R. Cashman M.D.CTO

Co-Founder, Co-Chairman of Scientific Advisory Board, Chief Scientific Officer & Director

Daniel E. Geffken M.B.A.CFO

Chief Financial Officer

Johanne Kaplan Ph.D.

Chief Development Officer

David Wishart Ph.D.

Chief Physics Officer

Dennis Chen Ph.D.

Head of Manufacturing & Senior Consultant

Total 8 executives

PMN Frequently asked questions

What is ProMIS Neurosciences, Inc. (PMN) Stock Price?

Current stock price of ProMIS Neurosciences, Inc. (PMN) stock is $13.970. The stock price is +4.68% higher in the session. The intraday range can be seen from this page. Volume of ProMIS Neurosciences, Inc. (PMN) stock is 89.57K.

Last updated at 02 Sept 2026, 08:00 pm.

Why is the ProMIS Neurosciences, Inc. (PMN) stock price going up or down today?

The stock price of ProMIS Neurosciences, Inc. (PMN) can change with earnings, company news, and overall market sentiment. ProMIS Neurosciences, Inc. operates in the Healthcare / Biotechnology market, so sector-wide moves can also affect the share price. Use the live price, percentage change, and volume on this page to judge whether a move looks meaningful.

Is the ProMIS Neurosciences, Inc. stock expensive at its current price?

Whether ProMIS Neurosciences, Inc. looks expensive depends on valuation metrics versus its growth outlook. The P/E ratio shown for PMN on this page is -1.20. EPS on this page is -11.66. Compare those figures with peers and growth expectations before deciding if the current ProMIS Neurosciences, Inc. price is justified.

How has the stock price of ProMIS Neurosciences, Inc. (PMN) performed historically?

Historical performance for ProMIS Neurosciences, Inc. (PMN) is shown on the price chart on this page. Review multi-period moves alongside volume to see how PMN reacted to past earnings and market events.

Should I buy ProMIS Neurosciences, Inc. (PMN) stock, at this price?

Buying ProMIS Neurosciences, Inc. (PMN) depends on your risk tolerance, time horizon, and portfolio needs. As a Healthcare name, weigh the live quote, key stats, and valuation links on this page rather than a single price point.